Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct;89(4):832-834.
doi: 10.1016/j.jaad.2023.04.075. Epub 2023 Jun 13.

Patient-reported outcomes with sarecycline treatment for acne vulgaris: Pooled analysis of phase 3 clinical studies

Julie C Harper  1 , April Armstrong  2 , Richard G Fried  3 , Evan A Rieder  4 , Andrew F Alexis  5 , Raidah J Salem  6 , Ismail Kasujee  7 , Ayman Grada  8
Affiliations
Free article

Patient-reported outcomes with sarecycline treatment for acne vulgaris: Pooled analysis of phase 3 clinical studies

Julie C Harper et al. J Am Acad Dermatol. 2023 Oct.
Free article
No abstract available

Keywords: Skindex-16; acne; dysbiosis; emotion; functioning; health-related quality of life; narrow-spectrum antibiotics; patient-reported outcomes; pediatric; sarecycline.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest JCH has served as a consultant and/or speaker for Almirall, Cassiopea, Cutera, EPI, Galderma, Journey, L’Oréal, Ortho Dermatologics, SolGel, Sun Pharmaceutical Industries, and Vyne. AA has served as a research investigator and/or scientific advisor to AbbVie, Boehringer Ingelheim, Bristol-Myers Squibb, Dermavant Sciences, Dermira, Eli Lilly and Company, EPI Health, Incyte, Janssen Pharmaceuticals, LEO Pharma, Novartis, Ortho Dermatologics, Pfizer, Regeneron Pharmaceuticals, Sanofi, Sun Pharmaceutical Industries, and UCB. RGF has served as a consultant to Almirall and Ortho Dermatologics. EAR has served as a consultant for Allergan, Almirall, Bristol-Myers Squibb, L’Oréal, Ortho Dermatologics, and UCB. AFA has received grant/research support (funds to institution) from Almirall, Amgen, Arcutis, Bausch Health, Bristol-Myers Squibb, Cara Therapeutics, Dermavant Sciences, Galderma, LEO Pharma, Menlo Therapeutics, and Novartis; has served as a consultant/advisory board member for AbbVie, Allergan, Almirall, Amgen, Arcutis, Bausch Health, Beiersdorf, Bristol-Myers Squibb, Cutera, Dermavant Sciences, Eli Lilly and Company, Galderma, Janssen Pharmaceuticals, LEO Pharma, L’Oréal, Pfizer, Sanofi-Regeneron, SolGel, Swiss American, UCB, VisualDx, and Vyne; and has served as a speaker for Bristol-Myers Squibb, Pfizer, and Sanofi-Genzyme. RJS and IK are employees of Almirall. AG is a former employee of Almirall.

Comment in

  • Acne and rosacea therapies see the light.
    Heymann WR. Heymann WR. J Am Acad Dermatol. 2023 Oct;89(4):675-676. doi: 10.1016/j.jaad.2023.07.1019. Epub 2023 Jul 29. J Am Acad Dermatol. 2023. PMID: 37524168 No abstract available.

Publication types